-
1 Comment
CellaVision AB (publ) is currently in a long term uptrend where the price is trading 23.1% above its 200 day moving average.
From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 15.6.
CellaVision AB (publ)'s total revenue sank by 41.3% to $88M since the same quarter in the previous year.
Its net income has dropped by 45.3% to $13M since the same quarter in the previous year.
Finally, its free cash flow grew by 23.4% to $22M since the same quarter in the previous year.
Based on the above factors, CellaVision AB (publ) gets an overall score of 3/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| ISIN | SE0000683484 |
| Sector | Healthcare |
| Industry | Medical Devices |
| PE Ratio | 27.78 |
|---|---|
| Dividend Yield | 1.6% |
| Target Price | None |
| Beta | 1.23 |
| Market Cap | 380M |
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers, instruments; and hardware products include in vitro diagnostics IVD for laboratories; as well as its portfolio includes smear makers, stainers, stains, and staining protocols; DIFF-Line is a hematology lab that handles a smaller amount daily blood samples and consists three instruments for smearing, staining, and analyzing peripheral blood smears CellaVision DC-1, RAL SmearBox, and RAL StainBox. It also provides CellaVision DC-1 for performing blood cell differentials; CellaVision DM1200 and CellaVision DM9600 are designed to automate and simplify the process of performing blood and body fluid differentials. In addition, its CellaVision Peripheral Blood Application enables laboratories to automate, standardize and simplify morphological examination like peripheral blood smears; CellaVision Advanced RBC Application performs a more comprehensive examination for red blood cell morphology; CellaVision Body Fluid Application is for examination body fluid preparations; CellaVision CellAtlas is an app with morphology experts for series mini lectures on extensive cell image library introduction to cell morphology; CellaVision Remote Review Software removes restrictive geographical constraints from smear review process and performs better; CellaVision Server Software creates a single streamlined workflow within one or multiple testing sites; and CellaVision VET is a veterinary lab. It sells its products to hospitals and commercial laboratories. The company was incorporated in 1994 and is based in Lund, Sweden.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for C26.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
